Department of Health and Human Services September 27, 2006 – Federal Register Recent Federal Regulation Documents
Results 1 - 9 of 9
Determination of Regulatory Review Period for Purposes of Patent Extension; LYRICA (New Drug Application 21-446)
The Food and Drug Administration (FDA) has determined the regulatory review period for LYRICA (new drug application (NDA) 21-446) and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims that human drug product.
Cost Allocation Methodology Applicable to the Temporary Assistance for Needy Families Program
The Administration for Children and Families proposes to regulate the cost allocation methodology to be used in the Temporary Assistance for Needy Families (TANF) program. The proposed rule would require States to use the ``benefiting program'' cost allocation methodology required by OMB Circular A-87 (2 CFR Part 225) and previously required under HHS' Office of Grants and Acquisition Management (OGAM) Action Transmittal (AT) 98-2.
Breast and Cervical Cancer Early Detection and Control Advisory Committee: Notice of Charter Renewal
Notice of Hearing: Reconsideration of Disapproval of Missouri State Plan Amendment 05-11
This notice announces an administrative hearing to be held on November 15, 2006, at the Richard Bolling Federal Building, 601 E. 12th Street, Kansas City, MO 64106-2898, the Kansas City Room, to reconsider CMS' decision to disapprove Missouri State plan amendment 05-11. Closing Date: Requests to participate in the hearing as a party must be received by the presiding officer by October 12, 2006.
Notice of Hearing: Reconsideration of Disapproval of New York State Plan Amendment 05-50
This notice announces an administrative hearing to be held on December 6, 2006, at 26 Federal Plaza, New York, NY 10278, Room 38- 110a, to reconsider CMS' decision to disapprove New York State plan amendment 05-50. Closing Date: Requests to participate in the hearing as a party must be received by the presiding officer by October 12, 2006.
Office of the National Coordinator for Health Information Technology; American Health Information Community Consumer Empowerment Workgroup Meeting
This notice announces the tenth meeting of the American Health Information Community Consumer Empowerment Workgroup in accordance with the Federal Advisory Committee Act (Pub. L. No. 92-463, 5 U.S.C., App.).
Oral Dosage Form New Animal Drugs; Amprolium Solution
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (ANADA) filed by IVX Animal Health, Inc. The ANADA provides for use of amprolium solution to make medicated drinking water or as a drench for the prevention or treatment of coccidiosis in calves.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
